OBJECTIVE: To demonstrate expression and regulation of prokineticins (PROKs) and their receptors (PROKRs) in fallopian tube (FT) from women who are not pregnant and women with ectopic pregnancy (EP). DESIGN: Tissue analysis. SETTING: Large United Kingdom teaching hospital. PATIENT(S): Women undergoing hysterectomy for benign gynecological conditions (n = 15) and surgery for EP (n = 16). INTERVENTION(S): Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry were used to determine FT PROK/PROKR messenger RNA (mRNA) expression and protein localization, respectively. The PROK/PROKR levels were measured in tubal explant cultures stimulated with estrogen (E) and progestogen. MAIN OUTCOME MEASURE(S): Differential expression of PROK and PROKR. RESULT(S): The FT PROK2 and PROKR1 mRNA levels were up-regulated during the P-dominant midluteal phase of the menstrual cycle. Increased PROKR1 expression was observed in tubal explant cultures treated with medroxy-progesterone acetate (MPA). The PROK and PROKR proteins were localized to the epithelium and smooth muscle layers of the FT. The PROKR1 and PROKR2 mRNA levels were lower in FT from women with EP compared with nonpregnant FT from the midluteal phase. CONCLUSION(S): These data suggest a potential role for PROKs in FT function. The PROKs are known to affect smooth muscle contraction in the gut. Dysregulated PROK expression in FT could affect FT smooth muscle contractility and embryo-tubal transport, providing a potential cause for EP.
OBJECTIVE: To demonstrate expression and regulation of prokineticins (PROKs) and their receptors (PROKRs) in fallopian tube (FT) from women who are not pregnant and women with ectopic pregnancy (EP). DESIGN: Tissue analysis. SETTING: Large United Kingdom teaching hospital. PATIENT(S): Women undergoing hysterectomy for benign gynecological conditions (n = 15) and surgery for EP (n = 16). INTERVENTION(S): Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry were used to determine FT PROK/PROKR messenger RNA (mRNA) expression and protein localization, respectively. The PROK/PROKR levels were measured in tubal explant cultures stimulated with estrogen (E) and progestogen. MAIN OUTCOME MEASURE(S): Differential expression of PROK and PROKR. RESULT(S): The FT PROK2 and PROKR1 mRNA levels were up-regulated during the P-dominant midluteal phase of the menstrual cycle. Increased PROKR1 expression was observed in tubal explant cultures treated with medroxy-progesterone acetate (MPA). The PROK and PROKR proteins were localized to the epithelium and smooth muscle layers of the FT. The PROKR1 and PROKR2 mRNA levels were lower in FT from women with EP compared with nonpregnant FT from the midluteal phase. CONCLUSION(S): These data suggest a potential role for PROKs in FT function. The PROKs are known to affect smooth muscle contraction in the gut. Dysregulated PROK expression in FT could affect FT smooth muscle contractility and embryo-tubal transport, providing a potential cause for EP.
Authors: Napoleone Ferrara; Gretchen Frantz; Jennifer LeCouter; Lisa Dillard-Telm; Thinh Pham; Aparna Draksharapu; Thomas Giordano; Franklin Peale Journal: Am J Pathol Date: 2003-06 Impact factor: 4.307
Authors: Jemma Evans; Rob D Catalano; Pamela Brown; Rob Sherwin; Hilary O D Critchley; Asgerally T Fazleabas; Henry N Jabbour Journal: FASEB J Date: 2009-03-02 Impact factor: 5.191
Authors: Cecilia Martin; Ravikumar Balasubramanian; Andrew A Dwyer; Margaret G Au; Yisrael Sidis; Ursula B Kaiser; Stephanie B Seminara; Nelly Pitteloud; Qun-Yong Zhou; William F Crowley Journal: Endocr Rev Date: 2010-10-29 Impact factor: 19.871
Authors: Julie L V Shaw; Elizabeth Oliver; Kai-Fai Lee; Gary Entrican; Henry N Jabbour; Hilary O D Critchley; Andrew W Horne Journal: Am J Pathol Date: 2010-09-23 Impact factor: 4.307
Authors: Julie L V Shaw; Gillian S Wills; Kai-Fai Lee; Paddy J Horner; Myra O McClure; Vikki M Abrahams; Nick Wheelhouse; Henry N Jabbour; Hilary O D Critchley; Gary Entrican; Andrew W Horne Journal: Am J Pathol Date: 2010-12-23 Impact factor: 4.307
Authors: Linsay J Macdonald; Kurt J Sales; Vivien Grant; Pamela Brown; Henry N Jabbour; Rob D Catalano Journal: Mol Hum Reprod Date: 2011-05-05 Impact factor: 4.025
Authors: Tamsin R M Lannagan; Martin R Wilson; Fiona Denison; Jane E Norman; Rob D Catalano; Henry N Jabbour Journal: Reproduction Date: 2013-10-23 Impact factor: 3.906
Authors: Julia Wilkens; Victoria Male; Peter Ghazal; Thorsten Forster; Douglas A Gibson; Alistair R W Williams; Savita L Brito-Mutunayagam; Marie Craigon; Paula Lourenco; Iain T Cameron; Kristof Chwalisz; Ashley Moffett; Hilary O D Critchley Journal: J Immunol Date: 2013-08-02 Impact factor: 5.422